Company Filing History:
Years Active: 1993
Title: Uwe-Peter Dammann: Innovator in Pharmaceutical Formulation
Introduction
Uwe-Peter Dammann is a notable inventor based in Detmold, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work in drug formulation. His expertise and creativity have led to the development of a patent that enhances the effectiveness of medicinal compounds.
Latest Patents
Dammann holds a patent for "Ifosfamide lyophilisate and process for its preparation". This patent details a lyophilized formulation that primarily contains ifosfamide combined with 0.1 to 17 parts by weight of a hexitol. This innovative formulation aims to improve the stability and efficacy of the drug, which is used in cancer treatment.
Career Highlights
Uwe-Peter Dammann is associated with Asta Pharma Aktiengesellschaft, a well-respected company in the pharmaceutical sector. His work has significantly contributed to advancements in drug formulation, showcasing his dedication to improving healthcare solutions.
Collaborations
Throughout his career, Dammann has had the opportunity to work with esteemed colleagues, including Dieter Sauerbier and Otto Isaac. These collaborations have allowed for a rich exchange of ideas and have enhanced the quality of innovation in their pharmaceutical projects.
Conclusion
Uwe-Peter Dammann's contributions to the field of pharmaceuticals through his patented formulation reflect his inventive spirit and commitment to improving medical treatments. His work not only demonstrates the impact of innovation in healthcare but also paves the way for future advancements in drug development.